332 studies found for:    ferritin
Show Display Options
Rank Status Study
1 Not yet recruiting Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
Conditions: Beta-thalassemia;   Serum Ferritin;   Iron Chelation Therapy
Intervention: Drug: desferal, ferriprox, blood transfusion
2 Recruiting Glycosylated Ferritin in Macrophagic Activation Syndromes
Conditions: Still's Disease, Adult-Onset;   Sepsis;   Macrophagic Activation Syndrome
3 Completed Effect of Timing of Umbilical Cord Clamping on Haematological and Clinical Outcomes of Infants
Conditions: Anemia;   Ferritin;   Complications;   Hemorrhage;   Jaundice
Interventions: Procedure: Early Cord Clamping;   Procedure: Delayed Cord Clamping
4 Completed DRIVE Trial (Dialysis Patients' Response to Intravenous [IV] Iron With Elevated Ferritin)
Conditions: Anemia, Iron-Deficiency;   Kidney Failure, Chronic;   Hemodialysis
Intervention: Drug: Sodium ferric gluconate,
5 Completed HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
Condition: Hereditary Hemochromatosis C282Y Homozygous
6 Completed
Has Results
Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Conditions: Iron Deficiency Anaemia;   Chronic Kidney Disease
Interventions: Drug: FCM (Ferric carboxymaltose) high ferritin target;   Drug: FCM (Ferric carboxymaltose) low ferritin target;   Drug: Oral Iron (Ferrous sulphate)
7 Suspended Interest of Biofer ® Compound Used in Blédilait Follow on Milk in Infant With Latent Iron Deficiency
Condition: Latent Iron Deficiency
Interventions: Drug: Bledilait Biofer®;   Drug: Milk supplemented with ferrous sulphate;   Drug: Blédilait Biofer®
8 Completed
Has Results
Iron Indices and Intravenous Ferumoxytol: Time to Steady State
Condition: Iron Deficiency Anemia
Intervention: Drug: ferumoxytol
9 Completed
Has Results
Clinical Evaluation of Iron Treatment Efficiency Among Non-anemic But Iron-deficient Female Blood Donors
Conditions: Fatigue;   Iron Deficiency
Interventions: Drug: Ferrous sulphate;   Drug: Placebo
10 Unknown  Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload
Conditions: Beta-thalassemia Major;   Sickle Cell Disease;   Iron Hemosiderosis
Interventions: Drug: DFP (ferriprox) and deferasirox (ICL 670);   Drug: DFP, DFO
11 Completed Timing of Iron Supplementation in Very Low Birth Weight Infants
Condition: Nutritional Status
Intervention: Drug: Elemental iron
12 Completed Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?
Conditions: Atherosclerosis;   Intermittent Claudication;   Peripheral Vascular Diseases
Intervention: Procedure: Ferritin reduction to 25 ng/ml by phlebotomy
13 Completed Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis
Conditions: Chronic Anemia;   Transfusional Hemosiderosis
Intervention: Drug: Deferasirox (ICL670)
14 Not yet recruiting An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients
Condition: Beta Thalassemia Major
Intervention: Drug: Deferiprone
15 Completed The Association of Ferrtin and Homocysteine Etc. With RI and MS in Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome
16 Completed Strategies to Reduce Iron Deficiency
Condition: Iron Deficiency
Interventions: Dietary Supplement: Ferrous gluconate- 19 mg;   Dietary Supplement: Ferrous gluconate- 38 mg;   Other: Letter Group- Information Provided
17 Completed Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
Condition: Iron Overload
Intervention: Drug: Deferasirox
18 Completed
Has Results
Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure
Conditions: Anemia;   Renal Failure
Interventions: Drug: Heme Iron Polypeptide (Proferrin);   Drug: Iron sucrose (Venofer)
19 Terminated
Has Results
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
Conditions: Anemia;   Unexplained Anemia
Intervention: Drug: iron sucrose
20 Recruiting Effect Of Intravenous Iron Versus Placebo On Muscle Oxidative Capacity And Physical Performance In Non Anemic Premenopausal Women With Low Ferritin Levels
Condition: Non Anemic Patients With Iron Deficiency (Low Ferritin Value)
Intervention: Drug: Double blind, randomized, placebo controlled inter

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years